Vaccine efficacy against the SARS-CoV-2 Delta variant during a COVID-19 outbreak aboard a military ship

被引：2
|
作者：
Maugey, Nancy [1 ]
Lefebvre, T. [2 ]
Tournier, J-N [3 ]
Neulat-Ripoll, F. [3 ]
Chapus, C. [3 ]
Grandperret, V [3 ]
Raynaud, F. [4 ]
Letois, F. [1 ,5 ]
Dutasta, F. [5 ]
Janvier, F.
Wolf, A. [6 ]
de Laval, F. [1 ,7 ]
机构：
[1] French Armed Forces Ctr Epidemiol & Publ Hlth, Marseille, France
[2] SSA French Mil Hlth Serv, Toulon, France
[3] French Armed Forces Biomed Res Inst, Bretigny Sur Orge, France
[4] CBRN Management, French Def Procurement Agcy DGA, Vert Le Petit, France
[5] Sainte Anne Mil Teaching Hosp, Toulon, France
[6] Begin Mil Teaching Hosp, St Mande, France
[7] Aix Marseille Univ, INSERM, IRD, SESSTIM Econ & Social Sci Hlth Syst & Med Informa, Marseille, France
来源：
BMJ MILITARY HEALTH | 2024年 / 170卷 / 01期
关键词：
D O I：
10.1136/bmjmilitary-2022-002082
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：91 / 92
页数：2
相关论文
共 50 条
  • [31] Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: a systematic review
    Du, Yuxuan
    Chen, Long
    Shi, Yuan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [32] Post COVID-19 condition of the Omicron variant of SARS-CoV-2
    Morioka, S.
    Tsuzuki, S.
    Suzuki, M.
    Terada, M.
    Akashi, M.
    Osanai, Y.
    Kuge, C.
    Sanada, M.
    Tanaka, K.
    Maruki, T.
    Takahashi, K.
    Saito, S.
    Hayakawa, K.
    Teruya, K.
    Hojo, M.
    Ohmagari, N.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (11) : 1546 - 1551
  • [33] Dynamics of serum cross-neutralization capacity against SARS-CoV-2 Delta variant in convalescent COVID-19 patients
    Nedelcu, Iulia
    Florian, Paula
    Ion, Daniel
    Militaru, Eliza
    Damalan, Anca
    Popescu, Costin-Ioan
    Hristea, Adriana
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (02)
  • [34] Repeated COVID-19 Relapse of an Imported Patient Infected with SARS-CoV-2 Delta Variant of Concern
    Ding, Songning
    Ma, Tao
    Huang, Rui
    Wang, Hengxue
    Liu, Jiacheng
    Wang, Jian
    Fan, Xiaomi
    Li, Jie
    Wu, Chao
    Zhou, Nan
    Fan, Huafeng
    CLINICAL LABORATORY, 2023, 69 (01) : 179 - 181
  • [35] Histopathological Lung Findings in COVID-19 B.1.617.2 SARS-CoV-2 Delta Variant
    Jeican, Ionut Isaia
    Inisca, Patricia
    Gheban, Dan
    Anton, Vlad
    Lazar, Mihaela
    Vica, Mihaela Laura
    Mironescu, Daniela
    Rebeleanu, Codrin
    Crivii, Carmen Bianca
    Aluas, Maria
    Albu, Silviu
    Siserman, Costel Vasile
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [36] Reconstruction of incidence reporting rate for SARS-CoV-2 Delta variant of COVID-19 pandemic in the US
    Smirnova, Alexandra
    Baroonian, Mona
    INFECTIOUS DISEASE MODELLING, 2024, 9 (01) : 70 - 83
  • [37] Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India
    Behera, Priyamadhaba
    Singh, Arvind Kumar
    Subba, Sonu Hangma
    Arjun, Mc
    Sahu, Dinesh Prasad
    Chandanshive, Pradnya Dilip
    Pradhan, Somen Kumar
    Parida, Swayam Pragyan
    Mishra, Abhisek
    Patro, Binod Kumar
    Batmanabane, Gitanjali
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (01)
  • [38] Detection of SARS-CoV-2 RNA in Medical Wastewater in Wuhan During the COVID-19 Outbreak
    Zhou, Jun-Bo
    Kong, Wen-Hua
    Wang, Sheng
    Long, Yi-Bing
    Dong, Lian-Hua
    He, Zhen-Yu
    Liu, Man-Qing
    VIROLOGICA SINICA, 2021, 36 (05) : 1077 - 1079
  • [39] Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
    Seyed Mehdi Sadat
    Mohammad Reza Aghadadeghi
    Masoume Yousefi
    Arezoo Khodaei
    Mona Sadat Larijani
    Golnaz Bahramali
    Molecular Biotechnology, 2021, 63 : 389 - 409
  • [40] Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
    Sadat, Seyed Mehdi
    Aghadadeghi, Mohammad Reza
    Yousefi, Masoume
    Khodaei, Arezoo
    Sadat Larijani, Mona
    Bahramali, Golnaz
    MOLECULAR BIOTECHNOLOGY, 2021, 63 (05) : 389 - 409
12345